NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»21/07/2009 [Industry news]
American Oriental Bioengineering, Elected a Top 20 Most Competitive Public Pharmaceutical Company in China

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China, today announced that AOBO was honorably elected as one of the Top 20 Most Competitive Public Pharmaceutical Companies in China.

 
American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China, today announced that AOBO was honorably elected as one of the Top 20 Most Competitive Public Pharmaceutical Companies in China. This event was jointly organized by Chinas leading healthcare industry associations, including the Chinese Pharmaceutical Enterprise Association and its publication, Healthcare Executive Magazine, and China\'s Center for Pharmaco-economics and Outcomes Research (CCPOR) at Beijing University, where an awards ceremony was held today. The 20 listed companies were selected from 132 Chinese pharmaceutical companies listed in Shanghai, Shenzhen, Hong Kong, Singapore, New York or on NASDAQ, as of February of this year. The selection criteria were based on the companies\' management capabilities, brand recognition, financial strength, resource accessibility and quality of key team members. Mr. Tony Liu, Chairman and Chief Executive Officer of American Oriental Bioengineering, commented: We are very honored to receive this recognition by the industry. This award speaks to the strength of our brand value and competitiveness in the changing environment. We will continue to focus on creating greater value for investors.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.